BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 19124283)

  • 1. Enzymatic diagnosis of Sjögren-Larsson syndrome using electrospray ionization mass spectrometry.
    Sanders RJ; Ofman R; Dekker C; Kemp S; Wanders RJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Feb; 877(4):451-5. PubMed ID: 19124283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoration of fatty aldehyde dehydrogenase deficiency in Sjögren-Larsson syndrome.
    Haug S; Braun-Falco M
    Gene Ther; 2006 Jul; 13(13):1021-6. PubMed ID: 16525484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sjögren-Larsson syndrome: diversity of mutations and polymorphisms in the fatty aldehyde dehydrogenase gene (ALDH3A2).
    Rizzo WB; Carney G
    Hum Mutat; 2005 Jul; 26(1):1-10. PubMed ID: 15931689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sjögren-Larsson syndrome is caused by mutations in the fatty aldehyde dehydrogenase gene.
    De Laurenzi V; Rogers GR; Hamrock DJ; Marekov LN; Steinert PM; Compton JG; Markova N; Rizzo WB
    Nat Genet; 1996 Jan; 12(1):52-7. PubMed ID: 8528251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sjögren-Larsson syndrome: seven novel mutations in the fatty aldehyde dehydrogenase gene ALDH3A2.
    Carney G; Wei S; Rizzo WB
    Hum Mutat; 2004 Aug; 24(2):186. PubMed ID: 15241804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adeno-associated virus vectors are able to restore fatty aldehyde dehydrogenase-deficiency. Implications for gene therapy in Sjogren-Larsson syndrome.
    Haug S; Braun-Falco M
    Arch Dermatol Res; 2005 Jun; 296(12):568-72. PubMed ID: 15834613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Indian family with Sjögren-Larsson syndrome caused by a novel ALDH3A2 mutation.
    Sakai K; Akiyama M; Yanagi T; Nampoothiri S; Mampilly T; Sunitha V; Shimizu H
    Int J Dermatol; 2010 Sep; 49(9):1031-3. PubMed ID: 20883264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sjögren-Larsson syndrome: molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency.
    Rizzo WB
    Mol Genet Metab; 2007 Jan; 90(1):1-9. PubMed ID: 16996289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosing Sjögren-Larsson syndrome in a 7-year-old Moroccan boy.
    Bernardini ML; Cangiotti AM; Zamponi N; Porfiri L; Cinti S; Offidani A
    J Cutan Pathol; 2007 Mar; 34(3):270-5. PubMed ID: 17302612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bezafibrate induces FALDH in human fibroblasts; implications for Sjögren-Larsson syndrome.
    Gloerich J; Ijlst L; Wanders RJ; Ferdinandusse S
    Mol Genet Metab; 2006; 89(1-2):111-5. PubMed ID: 16837225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum of mutations and sequence variants in the FALDH gene in patients with Sjögren-Larsson syndrome.
    Sillén A; Anton-Lamprecht I; Braun-Quentin C; Kraus CS; Sayli BS; Ayuso C; Jagell S; Küster W; Wadelius C
    Hum Mutat; 1998; 12(6):377-84. PubMed ID: 9829906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel assay for the prenatal diagnosis of Sjögren-Larsson syndrome.
    van den Brink DM; van Miert JM; Wanders RJ
    J Inherit Metab Dis; 2005; 28(6):965-9. PubMed ID: 16435189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sjögren-Larsson syndrome.
    Rizzo WB
    Semin Dermatol; 1993 Sep; 12(3):210-8. PubMed ID: 8217559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of fatty aldehyde dehydrogenase in the breakdown of phytol to phytanic acid.
    van den Brink DM; van Miert JN; Dacremont G; Rontani JF; Jansen GA; Wanders RJ
    Mol Genet Metab; 2004 May; 82(1):33-7. PubMed ID: 15110319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sjögren-Larsson syndrome due to a novel mutation in the FALDH gene.
    Botelho Gomes JM; Vieira AP; Navarro J; Maré R; Tavares P; Brito C
    Eur J Dermatol; 2011; 21(3):412-3. PubMed ID: 21524986
    [No Abstract]   [Full Text] [Related]  

  • 16. Sjögren-Larsson syndrome: report of monozygote twins and a case with a novel mutation.
    Yiş U; Terrinoni A
    Turk J Pediatr; 2012; 54(1):64-6. PubMed ID: 22397046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA-based mutation screening in German families with Sjögren-Larsson syndrome.
    Kraus C; Braun-Quentin C; Ballhausen WG; Pfeiffer RA
    Eur J Hum Genet; 2000 Apr; 8(4):299-306. PubMed ID: 10854114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First prenatal diagnosis by mutation analysis in a family with Sjögren-Larsson syndrome.
    Sillén A; Holmgren G; Wadelius C
    Prenat Diagn; 1997 Dec; 17(12):1147-9. PubMed ID: 9467812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sjögren-Larsson syndrome. Deficient activity of the fatty aldehyde dehydrogenase component of fatty alcohol:NAD+ oxidoreductase in cultured fibroblasts.
    Rizzo WB; Craft DA
    J Clin Invest; 1991 Nov; 88(5):1643-8. PubMed ID: 1939650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatty aldehyde dehydrogenase: genomic structure, expression and mutation analysis in Sjögren-Larsson syndrome.
    Rizzo WB; Lin Z; Carney G
    Chem Biol Interact; 2001 Jan; 130-132(1-3):297-307. PubMed ID: 11306053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.